Formidable Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Hold |
|
|||||
|
2025
Q1 | $156K | Sell |
|
|||||
|
2024
Q4 | $309K | Sell |
|
|||||
|
2024
Q3 | $425K | Sell |
|
|||||
|
2024
Q2 | $458K | Buy |
|
|||||
|
2024
Q1 | $604K | Buy |
|
|||||
|
2023
Q4 | $490K | Buy |
|
|||||
|
2023
Q3 | $385K | Buy |
|
|||||
|
2023
Q2 | $429K | Hold |
|
|||||
|
2023
Q1 | $384K | Sell |
|
|||||
|
2022
Q4 | $269K | Buy |
|
|||||
|
2022
Q3 | $261K | Buy |
|
|||||
|
2022
Q2 | $235K | Buy |
|
|||||
|
2022
Q1 | $379K | Buy |
|
|||||
|
2021
Q4 | $498K | Sell |
|
|||||
|
2021
Q3 | $633K | Buy |
|
|||||
|
2021
Q2 | $346K | Buy |
|
|||||
|
2021
Q1 | $278K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $263K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $14K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $29K | Sell |
|
|||||
|
2016
Q3 | $40K | Buy |
|
|||||
|
2016
Q2 | $61K | Buy |
|